
Costco (COST) shares slipped after reporting mixed Q4 results, with adjusted EPS and comparable sales exceeding expectations but decelerating comps and a slight decline in global membership renewal rates. Conversely, Eli Lilly (LLY) rose on President Trump's proposed 100% tariff on branded drug imports, while RH (W) shares tumbled following Trump's announcement of new tariffs on imported home products like kitchen cabinets and bathroom vanities.
Market activity reflects a split reaction to company-specific earnings and broader US trade policy announcements. Costco (COST) shares slipped despite reporting Q4 adjusted EPS and comparable sales (excluding gas and FX) that exceeded expectations. The negative investor sentiment stems from a deceleration in comparable sales growth from the prior quarter and a slight decline in global membership renewal rates, raising concerns about the sustainability of consumer momentum. In the political sphere, proposed tariffs created divergent outcomes. Eli Lilly (LLY) shares advanced after the announcement of a planned 100% tariff on branded drug imports, which the market perceives as a significant competitive advantage that could shield the domestic pharmaceutical firm from foreign competition. Conversely, RH (W) shares tumbled on news that the US will enact new tariffs on imported home goods such as kitchen cabinets and bathroom vanities, signaling strong investor concern over a direct, negative impact on the company's cost structure and profitability.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment